DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20182004

Study of serum angiotensin converting enzyme levels in pemphigus vulgaris

V. Anand Kumar, J. Vijaya Shree

Abstract


Background: This study aimed to evaluate the serum angiotensin converting enzyme (ACE) levels in patients with pemphigus vulgaris compared with healthy volunteers.

Methods: In this study, 40 patients were selected in the study group with pemphigus vulgaris and 40 patients were selected in the control group i.e. healthy group. Serum ACE levels were determined by spectrophotometric method.

Results: The mean ACE levels in study group and control group were 26.98±15.87 and 32.57±20.98 respectively. There was no statistically significant difference between both the groups (p=0.11). The mean ACE levels were 26.25±12.36 and 26.14±13.89 in females and males respectively in the study group which showed no significant difference (p=0.95). In the control group, the mean ACE levels were 26.22±19.77 and 38.54±11.11 in females and males respectively which showed a statistically significant difference (p=0.04). The mean ACE levels were higher in healthy males when compared to the males in the study group. The mean serum levels in females of both the groups were almost same.

Conclusions: The serum ACE level was considerably lower in male study group i.e. pemphigus vulgaris patients compared with male control group i.e. healthy group, despite lack of any significant difference of serum ACE level between pemphigus and control group. Hence, ACE might have some relation with pemphigus vulgaris especially in male patients.


Keywords


Pemphigus, Desmoglein

Full Text:

PDF

References


Brenner S, Goldberg I. Drug-induced pemphigus. Clin Dermatol. 2011;29:455-7.

Korman NJ, Eyre RW, Zone J, Stanley JR. Drug-induced pemphigus: Autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol. 1991;96:273-6.

Kuechle MK, Hutton KP, Muller SA. Angiotensin-converting enzyme inhibitor-induced pemphigus: Three case reports and literature review. Mayo Clin Proc. 1994;69:1166-71.

Vignes S, Paul C, Flageul B, Dubertret L. Ramipril-induced superficial pemphigus. Br J Dermatol. 1996;135:657-8.

Ong CS, Cook N, Lee S. Drug-related pemphigus and angiotensin converting enzyme inhibitors. Australas J Dermatol. 2000;41:242-6.

Steckelings UM, Wollschläger T, Peters J, Henz BM, Hermes B, Artuc M. Human skin: Source of and target organ for angiotensin II. Exp Dermatol. 2004;13:148-54.

Scholzen TE, Ständer S, Riemann H, Brzoska T, Luger TA. Modulation of Cutaneous Inflammation by Angiotensin-Converting Enzyme. J Immunol. 2003;170:3866–73.

Huskiæ J, Alendar F, Matavulj A, Ostoiæ L. Serum angiotensin converting enzyme in patients with psoriasis. Med Arh. 2004;58:202-5.

Alendar F, Huskić J, Babić N, Mulabegović N. Serum and tissue angiotensin converting enzyme in patients with lichen planus. Bosn J Basic Med Sci. 2005;5(3):59-62.

Robati RM, Ayatollahi A, Toossi P, Younespour S. Serum angiotensin converting enzyme in pemphigus vulgaris. Indian J Dermatol. 2014;59:348-51.

Beneteau-Burnat B, Baudin B, Morgant G, Baumannt FC, Giboudeau J. Serum Angiotensin-Converting Enzyme in Healthy and Sarcoidotic Children: Comparison with the Reference Interval for Adults. Clin Chem. 1990;36(2):344-6.

Mendelsohn FAO, Lloyd CJ, Kachel C, Funder JW. Glucocorticoid induction of angiotensin-converting enzyme production from bovine endothelial cells in culture and rat lung in vivo. Clin Exp Pharmacol Physiol. 1982;(7):57-62.

Krulewitz AH, Baur WE, Fanburg BL. Hormonal influence on endothelial cell angiotensin-converting enzyme activity. Am J Physiol. 1984;247:163-8.

Strittmatter SM, Thiele EA, De Souza EB, Snyder SH. Angiotensin- converting enzyme in the testis and epididymis: differential development and pituitary regulation of isozymes. Endocrinology. 1985;117:1374-9.

Velletri PA, Aquilano DR, Bruckwick E, Tsai-Morris CH, Dufau ML, Lovenberg W. Endocrinological control and cellular localization of rat testicular angiotensin-converting enzyme (EC 3.4.15.1). Endocrinology. 1985;116:2516-22.

Douglas GC, O'Bryan MK, Hedger MP, Lee DK, Yarski MA, Smith AI, et al. The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology. 2004;145:4703-11.

Mruk DD, Cheng CY. Desmosomes in the testis: Moving into an unchartered territory. Spermatogenesis. 2011;1:47-51.

Scholzen TE, Ständer S, Riemann H, Brzoska T, Luger TA. Modulation of cutaneous inflammation by angiotensin-converting enzyme. J Immunol. 2003;170:3866-73.